Fig. 1 | Scientific Reports

Fig. 1

From: MYBL2 promotes cell proliferation and inhibits cell apoptosis via PI3K/AKT and BCL2/BAX/Cleaved-caspase-3 signaling pathway in gastric cancer cells

Fig. 1

The expression level of MYBL2 was significantly correlated with the clinicopathological features of GC patients. (A–C) Kaplan-Meier analysis of the effect of MYBL2 expression on overall survival (A), progression-free survival (B), and post-progression survival (C) in GC patients. (D–E) MYBL2 expression in gastric mucosal tissues and GC tissues (D), MYBL2 expression in 27 paired of GC tissues and adjacent tissues (E). (F–H) MYBL2 expression level in normal gastric tissue and different grades (F), stages (G) and lymph node metastasis (H) of GC patients. **P < 0.01; ***P < 0.001; *: compared with normal gastric tissue.

Back to article page